Comment
. 1999 Feb 6;353(9151):495-6; author reply 497-8.
doi: 10.1016/S0140-6736(05)75165-5.
Interferon beta treatment for multiple sclerosis
- PMID: 9989741
- DOI: 10.1016/S0140-6736(05)75165-5
Item in Clipboard
Comment
Interferon beta treatment for multiple sclerosis
Lancet.
.
No abstract available
Comment on
-
Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS.Lancet. 1998 Nov 7;352(9139):1491-7. Lancet. 1998. PMID: 9820296 Clinical Trial.
-
Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.Lancet. 1998 Nov 7;352(9139):1498-504. Lancet. 1998. PMID: 9820297 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
